| CTRI Number |
CTRI/2025/07/090015 [Registered on: 02/07/2025] Trial Registered Prospectively |
| Last Modified On: |
01/07/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Understanding Spinal Muscular Atrophy in Children: Insights from a Public Hospital in Western India |
|
Scientific Title of Study
|
Clinical profile and diagnostic practices in children with spinal muscular atrophy - a retrospective study at a genetic clinic of a tertiary care public hospital in western India. |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Mamta Muranjan |
| Designation |
Professor |
| Affiliation |
Seth GS Medical College and KEM Hospital |
| Address |
Department of Pediatrics, Ward 1, Old KEM Hospital Building, KEM Hospital, Acharya Donde Marg, Parel, Mumbai, Maharashtra
Mumbai MAHARASHTRA 400012 India |
| Phone |
02224107647 |
| Fax |
|
| Email |
muranjanmamata@rediffmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Vedant Gaikwad |
| Designation |
Junior Resident |
| Affiliation |
Seth GS Medical College and KEM Hospital |
| Address |
Department of Pediatrics, Ward 2, Old KEM Hospital Building, KEM Hospital, Acharya Donde Marg, Parel, Mumbai, Maharashtra
Mumbai MAHARASHTRA 400012 India |
| Phone |
8451889411 |
| Fax |
|
| Email |
vedantg1010@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Mamta Muranjan |
| Designation |
Professor |
| Affiliation |
Seth GS Medical College and KEM Hospital |
| Address |
Department of Pediatrics, Ward 1, Old KEM Hospital Building, KEM Hospital, Acharya Donde Marg, Parel, Mumbai, Maharashtra
Mumbai MAHARASHTRA 400012 India |
| Phone |
02224107647 |
| Fax |
|
| Email |
muranjanmamta@rediffmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Seth GS Medical College and KEM Hospital |
| Address |
Seth GS Medical College and KEM Hospital, Acharya Done Marg, Parel, Mumbai 400012 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Mamta Muranjan |
Seth G.S. Medical College and K.E.M. Hospital |
Genetic clinic, Department of Pediatrics, Seth G.S. Medical College and K.E.M. Hospital, Parel, Mumbai 400012 Mumbai Maharashtra Mumbai MAHARASHTRA |
02224107647
muranjanmamata@rediffmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, IEC 2, Seth GS Medical College and KEM Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: G129||Spinal muscular atrophy, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
1.00 Day(s) |
| Age To |
18.00 Year(s) |
| Gender |
Both |
| Details |
All patients of any gender with childhood-onset SMA diagnosed at age less than or equal to 18 years based on genetic testing documenting biallelic deletion of exon 7 ± deletion of exon 8 or compound heterozygous disease-causing variants in the SMN1 gene. |
|
| ExclusionCriteria |
| Details |
1. Adult-onset SMA.
2. SMA caused by genes other than SMN1. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Enhanced understanding of SMA in our patient population: Compilation of comprehensive demographic and clinical data from the SMA patient cohort at our centre will provide valuable insights into prevalent disease subtypes, delays in referral and diagnosis, and highlight atypical presentations or complications. |
Single time point study at baseline. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| This study will identify errors in diagnostic practices prevalent in SMA & awareness of misdiagnosis with reference to genetic tests like MLPA, PCR, etc, especially in institutions lacking standardized protocols or access to genetic testing. |
1year |
| Investigate obstacles to effective treatment, including lack of patient awareness, affordability issues, and limited access to therapies, and thereby identify avenues for improvement in care delivery. |
|
|
|
Target Sample Size
|
Total Sample Size="55" Sample Size from India="55"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
14/07/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This retrospective study aims to evaluate the clinical profiles, diagnostic pathways, treatment modalities, and referral patterns of children with Spinal Muscular Atrophy (SMA) who have availed services at the Genetic Clinic of the Department of Paediatrics, Seth GS Medical College and KEM Hospital, Mumbai. The primary objective is to assess the clinical profile and diagnostic practices of SMA at a genetic clinic of a tertiary care public hospital. Secondary objectives focuses on the management strategies opted and barriers faced by SMA patients in timely diagnosis. Data collection will involve demographics, clinical features, diagnostic and treatment details, and patient outcomes. Key metrics include the time lag from symptom onset to diagnosis, factors contributing to delays, and differences in practices across SMA subtypes. Reasons for delayed presentation, including resource limitations, misinterpretation of symptoms, and systemic barriers, will also be examined. The study is ethically compliant, with data anonymization and confidentiality maintained. A waiver of informed consent will be sought as the study is retrospective and non-interventional. Statistical analyses will involve descriptive and inferential methods, using SPSS software. The findings are expected to provide insights into the challenges of diagnosing and managing SMA in India. By identifying gaps in early detection and treatment access, the study aims to inform strategies for improving care timeliness, resource allocation, and awareness among healthcare providers and families. Ultimately, the research seeks to enhance the quality of life for children with SMA by promoting better diagnostic and therapeutic practices within the Indian healthcare framework. |